Atlas Trials

GTX-RT in Borderline Resectable Pancreatic Cancer

Clinical trial NCT01754623 · TERMINATED

Trial details

NCT number
NCT01754623
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2013-02-01
Primary completion
2014-09-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.